Cadrenal Therapeutics, Inc. Common Stock (CVKD) — Financial Flexibility Index
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Financial Flexibility Index of -2.82x as of March 2026. Free cash flow of $-3.00 Million (operating CF $-3.00 Million minus capex $3.00) represents -3% of total liabilities ($1.06 Million). Check Cadrenal Therapeutics, Inc. Common Stock (CVKD) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cadrenal Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Cadrenal Therapeutics, Inc. Common Stock across 4 annual periods. See Cadrenal Therapeutics, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cadrenal Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Cadrenal Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see CVKD market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.93x | $-12.60 Million | $-12.60 Million | $1.59 Million | ▼ -189.6% |
| 2024 | -2.74x | $-7.35 Million | $-7.36 Million | $2.68 Million | ▲ +35.8% |
| 2023 | -4.27x | $-3.53 Million | $-3.53 Million | $826.88K | ▼ -2145.6% |
| 2022 | -0.19x | $-1.20 Million | $-1.20 Million | $6.33 Million | — |